Standard Lithium (NYSE:SLI) versus Koninklijke DSM (OTCMKTS:RDSMY) Head-To-Head Contrast

Koninklijke DSM (OTCMKTS:RDSMY) and Standard Lithium (NYSE:SLI) are both basic materials companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, valuation, dividends, profitability, earnings and institutional ownership.

Analyst Ratings

This is a breakdown of current recommendations and price targets for Koninklijke DSM and Standard Lithium, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Koninklijke DSM	0	0	0	0	N/A
Standard Lithium	0	0	1	0	3.00

Standard Lithium has a consensus target price of $3.50, indicating a potential upside of 114.72%. Given Standard Lithium’s higher possible upside, analysts clearly believe Standard Lithium is more favorable than Koninklijke DSM.

Insider & Institutional Ownership

0.2% of Koninklijke DSM shares are held by institutional investors. Comparatively, 16.8% of Standard Lithium shares are held by institutional investors. 3.7% of Standard Lithium shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Dividends

Koninklijke DSM pays an annual dividend of $0.37 per share and has a dividend yield of 1.1%. Standard Lithium pays an annual dividend of $2.00 per share and has a dividend yield of 122.7%. Standard Lithium pays out -869.6% of its earnings in the form of a dividend.

Profitability

This table compares Koninklijke DSM and Standard Lithium’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Koninklijke DSM	N/A	N/A	N/A
Standard Lithium	N/A	-15.67%	-14.05%

Valuation & Earnings

This table compares Koninklijke DSM and Standard Lithium”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Koninklijke DSM	$10.89 billion	2.17	$1.98 billion	N/A	N/A
Standard Lithium	N/A	N/A	-$31.35 million	($0.23)	-7.09

Koninklijke DSM has higher revenue and earnings than Standard Lithium.

Risk & Volatility

Koninklijke DSM has a beta of 1, meaning that its stock price has a similar volatility profile to the S&P 500.Comparatively, Standard Lithium has a beta of 1.89, meaning that its stock price is 89% more volatile than the S&P 500.

Summary

Standard Lithium beats Koninklijke DSM on 7 of the 11 factors compared between the two stocks.

About Koninklijke DSM

Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. It operates through Nutrition, Materials, and Innovation Center segments. The Nutrition segment offers animal nutrition and health products, including vitamins, premixes, carotenoids, enzymes, microbes, and eubiotics; human nutrition and health products comprising vitamins, nutritional lipids, minerals, carotenoids, nutraceuticals, digestive enzymes, probiotics, and prebiotics, as well as active pharmaceutical ingredients; premix, market-ready solutions, and personalized nutrition; human milk oligosaccharides; and skin and sun care, hair care, and aroma ingredients; omega-3 fatty acids; and specialty food enzymes, cultures, bio-preservation, texturizing hydrocolloids, sugar reduction, and savory taste solutions. The Materials segment provides specialty plastics used in components for the electrical and electronics, automotive, flexible food-packaging, and consumer goods industries; and Dyneema, a fiber solution for use in personal protection, workwear, sports apparel, outdoor equipment, ropes and slings, synthetic chains, and nets for the aquaculture, and renewable energy sectors. The Innovation Center segment offers biomedical materials, and medical device and material manufacturing technologies in the areas of cardiovascular, continence care, dental, diabetes management, gynecology, neurology, ophthalmology, orthopedic, peripheral vascular, plastic and reconstructive surgery, and wound management. It also commercializes yeast technology yeast for ethanol production. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands.

About Standard Lithium

Standard Lithium Ltd. explores for, develops, and processes lithium brine properties in the United States. Its flagship project is the Lanxess project with area of approximately 150,000 acres located in southern Arkansas. The company was formerly known as Patriot Petroleum Corp. and changed its name to Standard Lithium Ltd. in December 2016. Standard Lithium Ltd. was incorporated in 1998 and is headquartered in Vancouver, Canada.